MARKET

AXDX

AXDX

Accelerate
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.69
+0.69
+8.63%
Closed 16:39 03/30 EDT
OPEN
8.29
PREV CLOSE
8.00
HIGH
8.89
LOW
7.75
VOLUME
494.98K
TURNOVER
--
52 WEEK HIGH
24.00
52 WEEK LOW
4.530
MARKET CAP
477.20M
P/E (TTM)
-5.6181
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AXDX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AXDX stock price target is 15.00 with a high estimate of 16.00 and a low estimate of 14.00.

EPS

AXDX News

More
  • Daily Insider Ratings Round Up 3/27/20
  • Seeking Alpha - Article · 1d ago
  • SVM, ADMA, AHT and MITT among midday movers
  • Seeking Alpha - Article · 03/23 16:45
  • The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
  • Benzinga · 03/18 11:36
  • The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
  • Benzinga · 03/12 11:37

Industry

Advanced Medical Equipment & Technology
+3.53%
Healthcare Equipment & Supplies
+3.81%

Hot Stocks

Symbol
Price
%Change

About AXDX

Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. It detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate PhenoTest BC Kit provides ID and AST results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit.
More

Webull offers kinds of Accelerate Diagnostics Inc stock information, including NASDAQ:AXDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXDX stock news, and many more online research tools to help you make informed decisions.